Presentation ACC 2020 EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial Presenter: Deepak L. Bhatt March 30, 2020 REGISTER for free or LOG IN to view this content We Recommend Clinical Cardiology Prevention Clinical Pharma Lipids Coronary CAD Pharma Presentation ACC 2020 Icosapent ethyl EPA Vascepa Amarin